4//SEC Filing
Owens Daniel E. 4
Accession 0001209191-23-019944
CIK 0001630627other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:00 PM ET
Size
9.5 KB
Accession
0001209191-23-019944
Insider Transaction Report
Form 4
Owens Daniel E.
Chief HR Officer
Transactions
- Exercise/Conversion
Common Stock
2023-03-15$7.03/sh+6,250$43,925→ 37,164 total - Sale
Common Stock
2023-03-15$22.87/sh−6,250$142,956→ 30,914 total - Exercise/Conversion
Stock Option Right to Buy
2023-03-15−6,250→ 176,375 totalExercise: $7.03Exp: 2031-02-02→ Stock Option Right to Buy (6,250 underlying)
Footnotes (4)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 25,650 RSUs.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001858105
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:00 PM ET
- Size
- 9.5 KB